Results 151 to 160 of about 22,136 (209)

Weight Gain During SSRI Therapy: The Potential Role of the Gut Microbiota-A Narrative Review and Mechanistic Hypothesis. [PDF]

Nutrients
Śnieżek J, Polak-Szczybyło E.
europepmc   +1 more source

Comparative efficacy of agomelatine and escitalopram in people with epilepsy and comorbid major depressive disorder: A double-blind randomized controlled trial. [PDF]

Epilepsy Behav Rep
Fernandes M, Liguori C, Avvento F, Lombardi D, Manfredi N, Mari L, Izzi F, Castelli A, Pagano A, Di Mauro G, Giallonardo AT, Cerulli Irelli E, Di Bonaventura C, Romigi A, Mercuri NB, Placidi F.   +15 more
europepmc   +1 more source

Genotype influences antidepressant discontinuation in a pre-emptive pharmacogenetic testing population. [PDF]

Pharmacogenomics J
Baye JF, Petry NJ, Hines L, Weaver M, Reinke M, Brady H, Massmann A, Schultz A.   +7 more
europepmc   +1 more source

Gut-Brain Axis in Comorbid Constipation and Mood Disorders: Navigating the Efficacy-Tolerability Dilemma Through Emerging Evidence and Future Directions. [PDF]

Int J Gen Med
Tu M, Huang Y.
europepmc   +1 more source

Sandhoff Disease Associated With Bipolar Disorder: A Case Report From the United Arab Emirates. [PDF]

Cureus
Abdelrahman A, Alowais M, Elamin A, Ahmed AE, Rakhange A, Darweesh A, Adi AJ, Otour A.   +7 more
europepmc   +1 more source

Resting-state functional connectivity of the default mode network as a predictor for escitalopram response in adolescents with depression. [PDF]

Neuropsychopharmacology
Jang M, Lee KH, Shin J, Lee J, Yoo JH, Chun J, Ahn J, Kim JW.   +7 more
europepmc   +1 more source

Pharmacogenetic phenoconversion modeling of drug–drug–gene interactions on CYP2C19 activity: effects of comedication by genotype on escitalopram concentrations

Stingl J, Molden E, Hole K, Wollmann BM, Viviani R.   +4 more
europepmc   +1 more source